Keywords: عامل فلوتر 4; ADP; adenosine diphosphate; APC; activated protein C; AT-III; antithrombin III; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; CLP; cecal ligation - perforation; DIC; disseminated intravascular coagulation; LPS; lipopolysaccharide; IL-
مقالات ISI عامل فلوتر 4 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل فلوتر 4; critically ill; heparin; heparin-induced thrombocytopenia; thrombocytopenia; thrombosis; APTT; activated partial thromboplastin time; DIC; disseminated intravascular coagulation; DOAC; direct oral anticoagulant; ECMO; extracorporeal membrane oxygenation;
Keywords: عامل فلوتر 4; early diagnosis of HIT; heparin; HIT; plasma exchange, plasmapheresis; thrombocytopenia; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; OD; optical density; PEA; PF4-dependent P-selectin expression assay; PF4; platelet fa
Keywords: عامل فلوتر 4; 4 T's; The 4 T's score for the estimation of clinical pretest probability; LRÂ +; Â Positive Likelihood Ratio; LRÂ â; Â Negative Likelihood Ratio; HIT; Heparin-Induced Thrombocytopenia; HIPA; Heparin-Induced Platelet Activation assay; HPF4; Heparin-Plat
Keywords: عامل فلوتر 4; heparin-induced thrombocytopenia; type I; type II; platelet factor 4; enzyme-linked immunosorbent assay; optical density; serotonin-release assay; bivalirudin; argatroban; thrombosis; bleeding; transfusion; heart transplantation; platelet anesthesia; ilop
Keywords: عامل فلوتر 4; argatroban; danaparoid; fondaparinux; heparin; heparin-induced thrombocytopenia; lepirudin; EIA+/EIAâ; positive/negative platelet factor 4-dependent enzyme immunoassay; HIPA; heparin-induced platelet activation assay; HIPA+/HIPAâ; heparin-induced plat
Keywords: عامل فلوتر 4; Silk; Fibroin; Silica; Blood compatibility; EPR; enhanced permeability and retention; PEG; poly(ethylene glycol); LPS; lipopolysaccharides; PF4; platelet factor 4;
Keywords: عامل فلوتر 4; hemodialysis; platelet factor 4; antiplatelet; thrombosis; death;
Keywords: عامل فلوتر 4; 5HT; serotonin; ADP; adenosine-di-phosphate; β-TG; β-thromboglobulin; BMI; body mass index; CD40L; cluster of differentiation 40 ligand; ECG; electrocardiogram; ELISA; enzyme linked immunosorbent assay; ICAM; intercellular adhesion molecule; IPAQ; inter
Keywords: عامل فلوتر 4; Anti-FXa; anti-activated factor X (activity); aPTT; activated partial thromboplastin time; CTAD; citrate, theophylline, adenosine, dipyridamole; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FV; (coagulation) factor V; INR; inter
Keywords: عامل فلوتر 4; HIT; Heparin-induced thrombocytopenia; HD; Hemodialysis; PLT; platelet; PF4; platelet factor 4; GAGs; glycosaminoglycans; ULC; ultralarge complexes; LDL; low-density lipoprotein; AVF; arterio-venous fistula; AVG; arterio-venous graft; CVC; central venous
Keywords: عامل فلوتر 4; Gamma irradiation; RANTES; Platelet factor 4; Transforming growth factor β1; β ThromboglobulinRANTES, Regulated upon activation normal T cells expressed and secreted; PF-4, platelet factor 4; TGF-β, Transforming growth factor βeta; β TG, βeta Thromboglobu
Keywords: عامل فلوتر 4; heparin; platelet-activating antibodies; thrombocytopenia; thrombosis; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; OD; optical density; PF4; platelet factor 4; SRA; serotonin-release
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Keywords: عامل فلوتر 4; 4T; Thrombocytopenia, Timing of platelet count fall, Thrombosis or other sequelae, other causes of Thrombocytopenia; Ab; antibody; ACT; activated clotting time; aPTT; activated partial thromboplastin time; AVR; aortic valve repair; CABG; coronary artery b
The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelinesâ-Anticoagulation During Cardiopulmonary Bypass
Keywords: عامل فلوتر 4; ACT; activated clotting time; AmSECT; The American Society of Extracorporeal Technology; CPB; cardiopulmonary bypass; ECT; ecarin clotting time; ELISA; enzyme-linked immunosorbent assay; HIPA; heparin-induced platelet activation; HIT; heparin-induced thro
Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells
Keywords: عامل فلوتر 4; AP-1; activator protein 1; AP-1 c-Jun; c-Jun subunit of activator protein 1; bFGF; basic fibroblast growth factor; BrdU; bromodeoxyuridine; CURC; curcumin; DOX; doxorubicin; DPPC; 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine; FasL; Fas ligand; FCS; fetal c
Implementation of a rapid HIT immunoassay at a university hospital - Retrospective analysis of HIT laboratory orders in patients with thrombocytopenia
Keywords: عامل فلوتر 4; CLIA; chemiluminescent immunoassay; DTI; direct thrombin inhibitor; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; HIPA; heparin-induced platelet activation; HIT; heparin-induced thrombocytopenia; ICU; intensive care unit
Full Length ArticleThe causes of thrombocytopenia after transcatheter aortic valve implantation
Keywords: عامل فلوتر 4; F1Â +Â 2; prothrombin fragments 1Â +Â 2; MPV; mean platelet volume; PF-4; platelet factor 4; POD; postoperative day; PS; P-selectin; TAVI; transcatheter aortic valve implantation; Coagulation activation; Mechanisms of thrombocytopenia; Platelet activation
Effect of platelet-derived β-thromboglobulins on coagulation
Keywords: عامل فلوتر 4; CTAPIII; Connective Tissue Activating Peptide III; ETP; Endogenous thrombin potential; CTAPIII; Neutrophil Activating Peptide III; PBP; Platelet Basic Protein; βTG; Platelet-derived β-thromboglobulin; PF4; Platelet Factor 4; tpeak; Time to peak; TF; Tis
TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis
Keywords: عامل فلوتر 4; Eosinophil; esophagitis; SerpinE1; remodeling; fibrosis; TGF-β1; BZH; Basal zone hyperplasia; EoE; Eosinophilic esophagitis; LP; Lamina propria; LRP1; Lipoprotein receptor-related protein 1; MMP; Matrix metalloproteinases; PAI-1; Plasminogen activator
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis
Keywords: عامل فلوتر 4; heparin; thrombocytopenia; thrombosis; 4Ts; thrombocytopenia, timing of platelet count fall, thrombosis, and other causes of thrombocytopenia; AUC; area under the curve; GPIIb; glycoprotein IIb; HDH; high-dose heparin; HIT; heparin-induced thrombocytopeni
Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System
Keywords: عامل فلوتر 4; ELISA; Enzyme-linked immunosorbent assay; HEP; HIT expert probability; HIT; Heparin-induced thrombocytopenia; HITT; HIT with thrombosis; LMWH; Low molecular weight heparin; OD; Optical density; PF4; Platelet factor 4; SRA; Serotonin release assay; UFH; Un
Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia
Keywords: عامل فلوتر 4; BDNF; brain-derived neurotrophic factor; BMP; bone morphogenetic proteins; CXCR4; chemokine receptor type-4; ECs; endothelial cells; EGF; epidermal growth factor; FGF; fibroblast growth factor; GF; growth factors; HGF; hepatocyte growth factor; hSkMbs; hu
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - findings from the GerHIT multi-centre registry study
Keywords: عامل فلوتر 4; A; argatroban; aPTT; activated partial thromboplastin time; BMI; body-mass index; CRF; case report forms; CRO; Contract Research Organisation; D; danaparoid; DIC; disseminated intravascular coagulation; DTI; direct thrombin inhibitors; DVT; deep vein thro
New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells
Keywords: عامل فلوتر 4; PF4; platelet factor 4; Ab; antibodies; ASC; antibody-secreting cells; ELISA; enzyme-linked immunosorbent assay; ELISPOT; enzyme-linked immunospot assay; HIT; heparin-induced thrombocytopenia; EIA; enzyme-immunoassay; Ig; immunoglobulin; heparin-induced t
Diagnosis and Management of Heparin-Induced Thrombocytopenia
Keywords: عامل فلوتر 4; Platelet factor 4; PF4; Heparin; PF4/H complexes; HIT;
Embryonic stem cell differentiation system for evaluating gene functions involved in physiological megakaryocytic differentiation
Keywords: عامل فلوتر 4; Megakaryocyte; Platelet; Embryonic stem cells; Differentiation; Platelet factor 4; Glycoprotein IIb;
Prohibitin-1 deficiency promotes inflammation and increases sensitivity to liver injury
Keywords: عامل فلوتر 4; Phb; prohibitin; MCDD; methionine and choline deficient diet; LPS; bacterial lipopolysaccharide; PP2A; protein phosphatase 2 A; GSK; glycogen synthase kinase; ETF; electron transfer flavoportein; ADH; aldehyde dehydrogenase; AMPK; AMP kinase; IPA; Ingenui
Fondaparinux - data on efficacy and safety in special situations
Keywords: عامل فلوتر 4; ACS; acute coronary syndrome; anti-Xa; anti-factor Xa activity; APS; antiphospholipid syndrome; BID; twice a day; BMI; body mass index; DVT; deep vein thrombosis; EMA; European Medicines Agency; FDA; U.S. Food and Drug Administration; FEIBA; factor eight
Contribution of Surface Localization to Platelet Activation by CD154 Antibodies and Introduction of a Novel Approach for Studying Immune Complex Activity
Keywords: عامل فلوتر 4; ACD; acid-citrate-dextrose; HA-IgG; heat-aggregated IgG; HIT; heparin-induced thrombocytopenia; ICs; immune complexes; mAbs; monoclonal antibodies; PEG; polyethylene glycol; PF4; platelet factor 4; sCD154; soluble CD154; SRA; serotonin release assay; CD15
Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice
Keywords: عامل فلوتر 4; PF4; platelet factor 4; HUVEC; human umbilical vein endothelial cells; LDL; low density lipoproteins; Acrolein; Atherosclerosis; Endothelial cells; Lipoproteins; Platelets and PF4;
The Role of Platelet Factor 4 in Radiation-Induced Thrombocytopenia
Keywords: عامل فلوتر 4; Radiation-induced thrombocytopenia; Cytokines; Chemokines; Platelet factor 4; Thrombopoietin;
Propofol lowers serum PF4 level and partially corrects hypercoagulopathy in endotoxemic rats
Keywords: عامل فلوتر 4; 2D gel electrophoresis; Lipopolysaccharides; Platelet factor 4; Propofol; Rats
A novel mechanism of thrombosis in antiphospholipid antibody syndrome
Keywords: عامل فلوتر 4; β2-GPI; Platelet factor 4; HITT; Antiphospholipid syndrome; Autoantibodies
Development of a new magnetic beads-based immunoprecipitation strategy for proteomics analysis
Keywords: عامل فلوتر 4; BPH; Benign prostatic hyperplasia; CGH; comparative genome hybridization; CID; Collision-induced dissociation; GEO; Gene Expression Omnibus; GO; Gene Ontology; GSEA; Gene Set Enrichment Analysis; IP; Immunoprecipitation; KEGG; Kyoto Encyclopedia of Genes
Thrombocytopenia Exacerbates Cholestasis-Induced Liver Fibrosis in Mice
Keywords: عامل فلوتر 4; Bcl-2; Apoptosis; Cre; Conditional Knockout; ALP; alkaline phosphatase; α-SMA; α-smooth muscle actin; BDL; bile duct ligation; BrdU; 5-bromo-2-deoxyuridine; ECM; extracellular matrix; HGF; hepatocyte growth factor; HSCs; hepatic stellate cells; MMP; mat
Dual effect of Platelet Factor 4 on the activities of Factor Xa
Keywords: عامل فلوتر 4; Platelet Factor 4; Heparin; Prothrombin activation; Factor Va; Coagulation; Anticoagulation
Solidification mechanisms of chitosan–glycerol phosphate/blood implant for articular cartilage repair
Keywords: عامل فلوتر 4; Chitosan; Articular cartilage repair; Microfracture; Coagulation; Blood; Platelets; Platelet factor 4; Factor XIII; Factor VIIa; Thrombin; Tissue factor; Thrombin–antithrombin (TAT)
A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia
Keywords: عامل فلوتر 4; HIT; heparin-induced thrombocytopenia; PF4; platelet factor 4; LR; low risk; IR; intermediate risk; HR; high risk; ELISA; enzyme-linked immunosorbent assays; PPV; positive predictive value; NPV; negative predictive value; H/PF4; heparin/PF4; SRA; platelet
Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy
Keywords: عامل فلوتر 4; Allergen-specific immunotherapy; House dust mite allergy; Platelet activation; Platelet factor 4; Beta-thromboglobulin
High altitude: A hypercoagulable state: Results of a prospective cohort study
Keywords: عامل فلوتر 4; HA; high altitude; NO; Nitric Oxide; PAI-I; plasminogen activator inhibitor-I; AT III; anti-thrombin III; BTG; β thromboglobulin; PF 4; platelet factor 4; APC-R; Activated Protein C resistance; APTT; activated partial thromboplastin time; ACA; anti-cardi
Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis
Keywords: عامل فلوتر 4; SSc; systemic sclerosis; ADP; adenosine diphosphate; ATP; adenosine triphosphate; Pf4; platelet factor 4; TXA; thromboxane A2; PDGF; platelet-derived growth factor; TGF-β; tumor growth factor-β; CI; type I collagen; CIII; type III collagen; PRP; platele
Platelets in Atherothrombosis
Keywords: عامل فلوتر 4; ADP; adenosine diphosphate; CAPRIE; Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events; CD40L; CD40 ligand; CLARITY; Clopidogrel as Adjunctive Reperfusion Therapy; CLARITY-TIMI; Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in
Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support
Keywords: عامل فلوتر 4; 16; 22; 27; aPTT; activated partial thromboplastin time; CAA; column agglutination assay; EIA; enzyme immunoassay; HGW; Hansestadt Greifswald; HIPA; heparin-induced platelet activation assay; HIPA+&id/ IgG+; heparin-induced platelet activation assay posit
Platelet release of β-thromboglobulin and platelet factor 4 and serotonin in plasma samples
Keywords: عامل فلوتر 4; β-TG; β-thromboglobulin; PF4; platelet factor 4; TPA; 12-O-tetradecanoylphorbol 13-acetate; CTAD; citrate-theophylline-adenosine-dipyridamole; Plasma; Platelet factor 4 (PF4); Serotonin; β-thromboglobulin (β-TG);
Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome
Keywords: عامل فلوتر 4; anaphylactoid reaction; heparin; IgG; skin lesions; thrombocytopenia; DVT; deep-vein thrombosis; HIT-IgG; heparin-induced thrombocytopenia IgG antibodies; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; PF4; platelet factor 4; U
Platelet factor 4: a chemokine enigma
Keywords: عامل فلوتر 4; Platelet factor 4; Thrombosis; Protein C; Thrombomodulin;
Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery
Keywords: عامل فلوتر 4; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; HIT(T); heparin-induced thrombocytopenia and thrombosis; Ig; immunoglobulin; OD; optical density; OR; odds ratio; PF4; platelet factor 4; 18; 25;
Association of Heparin-Dependent Antibodies and Adverse Outcomes in Hemodialysis Patients: A Population-Based Study
Keywords: عامل فلوتر 4; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; ERSD; end-stage renal disease; HIPA; heparin-induced platelet aggregation; HIT; heparin-induced thrombocytopenia; OD; optic density; PF4; platelet factor 4;
Chemokines in Myocardial Ischemia
Keywords: عامل فلوتر 4; GRO-α; Growth-Regulated Oncogene-α; IL-1β; Interleukin-1β; IL-8; Interleukin-8; IL-10; Interleukin-10; IP-10; Interferon-γ-Inducible Protein-10; MCP-1; Monocyte Chemoattractant Protein-1; MIG; Monokine Induced by γ-Interferon; MIP-1α, -β; Macropha